NEWS FROM USA
New Paragraph IV filing
|
DRUG |
Dosage form |
Corresponding RLD |
Date of Submission |
Type of Submission (Based on Date) |
|
Carfilzomib (10 mg/vial) |
Injection |
Kyprolis |
28 Nov 2018 |
Post NCE-1 submission for new strength |
|
Nintedanib |
Softgel Capsules |
Ofev |
15 Oct 2018 |
NCE-1 |
NDA Approvals
|
Approval Date |
Drug |
NDA Sponsor |
Brand Name |
Prescribing information |
|
19 Dec 2018 |
Diclofenac Epolamine Shampoo (505(b)2 approval) |
Institut Biochimique |
Licart |
|
|
21 Dec 2018 |
Levetiracetam extended release (505(b)2 approval) |
Sun Pharma |
Elepsia XR |
505 (b) 2s in pipeline
Asenapine transdermal patch (Hisamitsu): Hisamitsu submits New Drug Application of Asenapine transdermal patch in the US.
Minocycline foam 4% (Foamix): Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne.
ANDA Approvals
|
Approval Date |
Drug Product |
ANDA Sponsor |
Corresponding RLD |
Number Of Other Approved Generics |
|
19 Dec 2018 |
Puracap Pharma |
Tessalon (Pfizer) |
Ten |
|
|
19 Dec 2018 |
Unichem |
Mirapex (Boehringer) |
Fourteen |
|
|
19 Dec 2018 |
Twi Pharms |
Toprol-Xl(Aralez) |
Seven |
|
|
19 Dec 2018 |
Aurobindo |
Klor-Con (Upsher) |
Six |
Tentative ANDA Approvals
|
Approval Date |
Drug |
Company |
|
19 Dec 2018 |
Torrent |
Other News from the USA
FDA publishes updated list of Off-Patent, Off-Exclusivity Drugs without an Approved Generic (Link)
If you have any query/suggestion then please write us at pharmacaption@gmail.com
No comments:
Post a Comment